VAUGHAN, Ontario--(BUSINESS WIRE)-- Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that the U.S.
A discussion of his situation led to the selection of the enVista Envy IOL. One month postoperatively, the patient achieved 20/20–2 vision bilaterally, with a small amount of myopia in the right eye ...
Please provide your email address to receive an email when new articles are posted on . Two clinical trials have demonstrated positive results for the full range of vision IOL. Bausch + Lomb ...
enVista Envy full range of vision intraocular lens (IOL) met all primary efficacy and safety endpoints in multicenter study Results show that enVista Envy IOLs deliver excellent visual performance, ...
Patients exploring options for cataract surgery or Custom Lens Replacement now have access to one of the most advanced intraocular lenses available—the Bausch + Lomb enVista Envy lens—offered at ...
Envy delivers outstanding performance in all lighting conditions thanks to ActivSync Optic intelligent energy distribution, which optimizes vision in many lighting conditions. Envy also enables ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results